ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Kei Sakuma
Koichi Tabayashi
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sakuma, K.
Right arrow Articles by Tabayashi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sakuma, K.
Right arrow Articles by Tabayashi, K.
Related Collections
Right arrow Pericardium

Ann Thorac Surg 2005;80:1835-1840
© 2005 The Society of Thoracic Surgeons


Original article: Cardiovascular

Closure of the Pericardium Using Synthetic Bioabsorbable Polymers

Kei Sakuma, MD a , * , Atsushi Iguchi, MD a , Yoshito Ikada, MD b , Koichi Tabayashi, MD a

a Department of Cardiovascular Surgery, Graduate School of Medicine, Tohoku University, Sendai, Japan
b Department of Medical Electronics, Suzuka University of Medical Science, Sendai, Japan

Accepted for publication April 27, 2005.

* Address correspondence to Dr Sakuma, Department of Cardiovascular Surgery, Graduate School of Medicine, Tohoku University, 1-1 Seiryomachi Aoba-ku, Sendai 980-8574, Japan (Email: ksakuma{at}mail.tains.tohoku.ac.jp).


    Abstract
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
BACKGROUND: Pericardial substitutes are known to ensure safer resternotomy at reoperation. A synthetic sheet made from expanded-polytetrafluoroethylene (e-PTFE) has been most commonly used as a pericardial substitute. The e-PTFE sheet, however, can induce severe inflammatory reaction and diffuse fibrosis. This study was designed to investigate the absorption rate and tissue reaction associated with two absorbable pericardial substitutes: a gelatin sheet and L-lactic acid-{varepsilon}-caprolactone copolymer (L-C copolymer). In addition, e-PTFE sheet and autologous pericardium were used as controls.

METHODS: Sixty dogs were divided into four groups of 15. In group A, a 3 x 3 cm segment of pericardium was excised, and the autologous pericardium was resutured. In group B, the pericardial defect was replaced with gelatin sheet. In group C, the defect was replaced with L-C copolymer sheet. In group D, the defect was replaced with e-PTFE sheet. For each group, the implanted membranes were retrieved at 2 weeks (n = 1), 4 weeks (n = 3), 12 weeks (n = 5), and 24 weeks (n = 6) after implantation.

RESULTS: The e-PTFE sheet produced severe adhesions to the heart and pleura and a more prominent inflammatory reaction, as compared with the gelatin sheet. The absorbable pericardial substitutes were completely absorbed by 24 weeks after implantation, and were replaced with fibrous membrane.

CONCLUSIONS: Gelatin sheet may involve less adhesion and a reduced inflammatory reaction compared with e-PTFE.


    Introduction
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
Primary closure of the pericardium is recommended to reduce the formation of adhesions between the heart and chest wall. In some patients, autologous pericardium cannot be used (for various reasons), and pericardial substitutes should be employed in order to secure safer resternotomy at reoperation.

Several materials can be used as pericardial substitutes, including silicone rubber [1], polyurethane [2], fascia lata [3, 4], expanded-polytetrafluoroethylene (e-PTFE) sheet [2, 5, 6], heterologous porcine, equine, or bovine pericardium [7–10], Dacron [11, 12], and dura mater [13]. However, several drawbacks have been reported with the use of pericardial substitutes—including dense adhesions and severe inflammatory reactions. At reoperation, these complications give rise to longer operative and perfusion times, bleeding, and injury to the heart or great vessels. And, occasionally, the use of foreign material for pericardial substitutes causes mediastinitis that emerges as a profound complication after open heart surgery. Recently, many authors have described materials that reduce the formation of adhesion in the retrosternal space [14, 15]. These materials, however, are not yet widely used because of possible problems associated with their clinical application. On the other hand, Yamada and associates [16] described in 1997 a composite bioabsorbable sheet, composed of two copolymer films of L-lactic acid-{varepsilon}-caprolactone (50% L-lactic acid, 50% {varepsilon}-caprolactone) and a poly(glycolic acid) nonwoven fabric, which displayed good mechanical properties, was completely absorbed by 24 weeks after implantation in the back of rats, and was replaced with the regenerated duralike tissue in dural defects in rabbits. They concluded that this new bioabsorbable composite sheet can be successfully used as a dural substitute.

The present study was designed to investigate the absorption rate and the tissue reaction to two absorbable pericardial substitutes: gelatin sheet [24] and L-lactic acid-{varepsilon}-caprolactone copolymer (L-C copolymer). In addition, the most commonly used e-PTFE sheet and autologous pericardium were used as controls.


    Material and Methods
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
Sixty-two dogs weighing from 8 to 27 kg (mean, 12 kg) were used as a pericardial reconstruction model. There were 2 early deaths: one dog died of hypotension just after anesthetization and the other died of unknown causes 1 day after operation. The remaining 60 dogs were reoperated upon between 2 and 24 weeks postoperatively.

Animal care was in compliance with the Principles of Animal Use formulated by the Animal Use Committee at Tohoku University.

Experimental Groups and Pericardial Substitutes
The animals were divided into four groups of 15 dogs each. In group A, were the controls (a segment of pericardium was excised, and the autologous pericardium was resutured). In group B, the pericardial defect was replaced with a 0.1-mm thick gelatin sheet (Gunze, Kyoto, Japan). In group C, the pericardial defect was replaced with a 0.4-mm thick L-lactic acid-{varepsilon}-caprolactone (50:50) copolymer sheet (Gunze). In group D, the defect was replaced with 0.1-mm thick expanded-polytetrafluoroethylene (E-PTFE) sheet (W.L. Gore & Associates, Elkton, Maryland).

The fabrication processes for the gelatin sheet and L-C copolymer (50:50) sheet are described below.

Gelatin Sheet
Gelatin, extracted from bovine bone (type I collagen) using the alkaline method, was donated by Nitta Gelatin (Osaka, Japan). To prepare gelatin films, gelatin powder was dissolved in distilled water to a concentration of 10 wt%. The solution was cast on glass plates and allowed to dry in air, yielding gelatin films of 0.1 mm in thickness. Cross-linking was introduced by exposing both sides of the gelatin films to ultraviolet light for 10 hours, in air, at 60 cm from a 15-W ultraviolet lamp (Toshiba GL-15). The sheet was ready for use as a pericardial substitute after sterilization with ethylene oxide gas [17].

L-Lactic Acid-{varepsilon}-Caprolactone (50/50) Copolymer Sheet (50:50) Sponge Sheet
The L-C copolymer (50:50 mol%, Mw = 220,000) was dissolved in 1,4-dioxane to a concentration of 6 wt%. This solution was poured into a mold and was frozen at –135°C. Then, the frozen content was freeze-dried to yield a porous sponge sheet of 0.5-mm thickness. This sponge sheet was completely dried at 70°C for 12 hours in vacuo. The sheet was ready for use as a pericardial substitute after sterilization with ethylene oxide gas [17].

Surgical Procedure
An intravenous line and electrocardiographic monitoring were established. Anesthesia was induced with 2.5% sodium thiopental at a dose of 25 mg/kg, and maintained with halothane in oxygen. Mechanical ventilation was instituted with an approximate tidal volume set at 10 mL/kg body weight, with 100% oxygen, at a rate of 8 to 14 cycles per minute. Under sterile conditions, a left lateral thoracotomy incision was made through the fourth or fifth intercostal space. After pericardial fat and feeding vessels were carefully separated and the surface of the pericardium was exposed, a 3 x 3 cm segment of pericardium was excised about 1 cm anterior to the phrenic nerve. After scattering 5 mL of autologous blood into the pericardial defect (in order to promote the formation of adhesions), a sheet was anchored to the surrounding pericardium with 5-0 Prolene (Ethicon, Somerville, New Jersey) mattress sutures. Care was taken to avoid contact with the epicardial surface of the heart. Prophylactic antibiotics (cefazolin sodium 40 mg/kg) were given intravenously just after the operation.

Dogs were sacrificed at 2 to 24 weeks after operation and the en bloc heart, including the pericardium and left lung, was removed through a left-sided thoracotomy. The implant tissue sites were then examined and photographed.

Evaluations
The survival rates for the 4 groups were 100% (group A), 93% (group B), 93% (group C), and 100% (group D). The implanted membranes were retrieved (from each group) at 2 weeks (n = 1), 4 weeks (n = 3), 12 weeks (n = 5), and 24 weeks (n = 6) after implantation. Adhesion formation was evaluated by macroscopic findings—particularly in the pleura or the lung-to-pericardium (P) and pericardium-to-epicardium (E) interfaces. The degree of adhesion was quantitatively classified from 0 to 3, using the adhesion score of Heydorn and colleagues [18]: 0 = no adhesion; 1 = adhesion could be readily separated by finger dissection; 2 = adhesion is of intermediate strength; and 3 = adhesion necessitated sharp dissection.

In each animal, specimens of myocardium, epicardium, and pericardium were taken for light microscopic studies. These were fixed in 10% phosphate-buffered formalin for at least 3 days, embedded in paraffin, and sectioned at 5 µm. Then, sections were stained with hematoxylin-eosin and elastica-Masson in order to assess inflammatory reaction as well as changes in the pericardial substitutes themselves.

Escalating severity of the inflammatory reaction was histopathologically defined by increasing numbers of infiltrating inflammatory cells and inflammatory foci. The inflammatory reaction of each sheet was quantitatively classified from 0 to 3, using the inflammatory reaction score reported by Lu and colleagues [19]: 0 = no cell infiltration; 1 = sparse, focal infiltration of neutrophils, lymphocytes, and plasma cells; 2 = focal infiltration of neutrophils, plasma cells, and lymphocytes; 3 = diffuse infiltration of neutrophils, plasma cells, and lymphocytes. The fibrous reaction was quantitatively classified from 0 to 3, using the fibrous reaction score reported by Lu and coworkers [19]: 0 = no fibrous reaction; 1 = sparse, focal fibrous connective tissue, hyalinization, and fibrin deposition; 2 = a thin layer of fibrous connective tissue, hyalinization, and fibrin deposition; and 3 = a thick layer of fibrous connective tissue, hyalinization, and fibrin deposition. Adhesion, inflammatory reaction, and fibrous reaction were evaluated by the same two pathologists, who were masked to the treatment. Quoted scores were the mean of the two scores classified by the pathologists.

Finally, the fibrous membrane was observed using cytokeratin immunohistochemistry.

Statistical Methods
Results are expressed as mean ± SD. Analysis of variance (ANOVA) and the Scheffe test for post-hoc comparison were used to evaluate differences among the four groups. A p value of less than 0.05 was considered to be significant for the test.


    Results
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
All of the animals survived implantation and were evaluated as scheduled.

After 2 weeks, there were no adhesions of either pleura-to-pericardium or pericardium-to-epicardium, and no differentiation between the four groups.

After 4 weeks, group A demonstrated minimal adhesion of the autologous pericardium, and the adhesions of both pleura-to-pericardium and pericardium-to-epicardium could be separated by finger in 1 dog. However, these findings were not consistent. In another 2 animals, autologous pericardium had moderately or completely adhered to the underlying epicardium. In group B, a thin membrane had replaced the gelatin sheet with no adhesions within the pericardium, in all animals, and the membrane was covered with autologous tissue and lung. In group C, the membrane had incompletely replaced the original caprolactone sheet; the degree of epicardial adhesion was none in 1 dog and minimal to moderate in the other 2 dogs. In group D, 2 dogs had no adhesions between the pleura and the e-PTFE seat or the between e-PTFE seat and the epicardium, but dense adhesion was observed in 1 dog.

After 12 weeks, group A adhesions were absent in 2 dogs and moderate in 3 dogs (between the pericardium and epicardium). Adhesions between the pericardium and pleura were minimal in 3 dogs and moderate in 2 dogs. In group B, the pericardial space was free of adhesions in 4 of 5 dogs and there were no adhesions between the pleura and pericardium in 4 of 5 dogs. One dog had minimal adhesion in both interfaces. In group C, 2 dogs had moderate adhesion between the pericardium and epicardium, and 3 had none. Adhesion between the pericardium and pleura was minimal in 3 and moderate in 2. In group D, dense adhesion was seen between the e-PTFE sheet and the epicardium in 1 of 5 dogs, while adhesion was moderate in 3 dogs and minimal in 1.

After 24 weeks, in group A, adhesion between the pericardium and epicardium was absent in 1 dog, minimal in 3 dogs, and tight in 2 dogs; adhesion between the pericardium and pleura was absent in 1 dog, minimal in 2 dogs, moderate in 2 dogs, and tight in 1 dog. In group B, the pericardial space was free of adhesions in 5 of 6 dogs, and no dog had adhesions between the pleura and pericardium. In group C, the original caprolactone sheet was completely replaced by a thin membrane in 4 of 6 dogs, but only incompletely in 2 dogs. Adhesion between the pericardium and epicardium was absent in 3 dogs, minimal in 1, and moderate in 2. Adhesion between the pericardium and pleura was absent in 2 dogs, minimal in 2, and moderate in 2. In group D, dense adhesion was seen between the e-PTFE sheet and the epicardium in 4 of 6 dogs; adhesion here was moderate in 1 dog and absent in the remaining dog.

The macroscopic results are summarized in Tables 1 and 2 Go (numbers represent mean ± SD of the adhesion scores). Adhesion formation on the gelatin sheet, both the pleural side and the pericardial side, was significantly less than on the e-PTFE sheet, at 12 and 24 weeks after operation (p < 0.05).


View this table:
[in this window]
[in a new window]
 
Table 1. Adhesion Score Epicardial Side
 

View this table:
[in this window]
[in a new window]
 
Table 2. Adhesion Score Pleural Side
 
Microscopic Evaluation
After 2 weeks, group A demonstrated sparse focal neutrophils, lymphocytes, and plasma cell infiltration (Fig 1A). In group B, a small part of the gelatin was absorbed (Fig 1B). In group C, only part of the L-C copolymer sheet was absorbed, and granulous tissue formed on one piece (Fig 1C). In group D, neutrophil infiltration was extensive around the e-PTFE sheet (Fig 1D).



View larger version (117K):
[in this window]
[in a new window]
 
Fig 1. (A) Group A, autologous pericardium at 2 weeks after implantation. (B) Group B, gelatin sheet at 2 weeks after implantation. (C) Group C, L-lactic acid-{varepsilon}-caprolactone copolymer at 2 weeks after implantation. (D) Group D, expanded-polytetraflurorethylene sheet at 2 weeks after implantation.

 
After 4 weeks, in group A, sparse focal neutrophils, lymphocytes, and plasma cell infiltration were observed (Fig 2A). In group B, a considerable portion of the gelatin sheet was absorbed. At the site of the remaining gelatin, a slight inflammatory reaction was observed (Fig 2B). In group C, only part of the L-C copolymer sheet was absorbed and one piece showed granulous tissue formation (Fig 2C). In group D, neutrophil infiltration was extensive around the e-PTFE sheet (Fig 2D).



View larger version (140K):
[in this window]
[in a new window]
 
Fig 2. (A) Group A, autologous pericardium at 4 weeks after implantation. (B) Group B, gelatin sheet at 4 weeks after implantation: no inflammatory reaction was observed. (C) Group C, L-lactic acid-{varepsilon}-caprolactone copolymer at 4 weeks after implantation: piece of the L-C copolymer formed granulation tissue. (D) Group D, expanded-polytetrafluoroethylene (e-PTFE) sheet at 4 weeks after implantation: neutrophil infiltration is extensive around the e-PTFE seat.

 
After 12 weeks, in group A, neutrophils, lymphocytes, and plasma cell infiltration were decreased; slight thickening of the fibrous tissue was observed (Fig 3A). In group B, almost no inflammatory reaction was observed (Fig 3B). In group C, some amount of granulous tissue and a surrounding thin layer of fibrous connective tissue were observed (Fig 3C). In group D, sparse, focal and diffuse neutrophils, lymphocytes, and plasma-cell infiltration were observed around the e-PTFE sheet (Fig 3D).



View larger version (130K):
[in this window]
[in a new window]
 
Fig 3. (A) Group A, autologous pericardium at 12 weeks after implantation. (B) Group B, gelatin sheet at 12 weeks after implantation. (C) Group C, L-lactic acid-{varepsilon}-caprolactone copolymer at 12 weeks after implantation. (D) Group D, expanded-polytetrafluoroethylene sheet at 12 weeks after implantation.

 
After 24 weeks, in group A, almost no inflammatory reaction was observed (Fig 4A). In group B, the gelatin sheet was completely absorbed and replaced by autologous membrane with sparse fibrous tissue. No inflammatory reaction was observed (Fig 4B). In group C, the L-C copolymer seat was almost replaced by a thin layer of fibrous connective tissue, with some amount of granulation (Fig 4C). In group D, infiltration of neutrophils, lymphocytes, and plasma cells was observed around the e-PTFE sheet (Fig 4D).



View larger version (139K):
[in this window]
[in a new window]
 
Fig 4. (A) Group A, autologous pericardium at 24 weeks after implantation. (B) Group B, gelatin sheet at 24 weeks after implantation: at the site of the remaining gelatin sheet, it has a light inflammatory reaction. (C) Group C, L-lactic acid-{varepsilon}-caprolactone copolymer at 24 weeks after implantation: the copolymer sheet was almost replaced by a thin layer of fibrous connective tissue with some amount of granulation tissue. (D) Group D, the expanded-polytetrafluoroethylene (e-PTFE) sheet at 24 weeks after implantation: the e-PTFE sheet consisted of dense connective tissue.

 
The microscopic inflammation scores are summarized in Table 3 (numbers represent mean ± SD of the inflammation scores). Inflammatory reaction scores were high after 4 weeks and decreased after 12 weeks, in all four groups. Group A had a tendency to increase after 24 weeks. Inflammatory reaction scores in group D tended to be high after 24 weeks, especially in comparison to group B, but the difference was not statistically significant.


View this table:
[in this window]
[in a new window]
 
Table 3. Inflammation Score
 
The microscopic fibrous reaction scores are summarized in Table 4 (numbers represent mean ± SD of the fibrous reaction scores). Fibrous reaction scores were high after 4 weeks and decreased after 12 weeks, in all four groups. Groups A and B had a tendency to increase after 24 weeks. Fibrous reaction scores paralleled the inflammatory reaction scores. In group A, fibrous reaction scores tended to be lower than in the other three groups.


View this table:
[in this window]
[in a new window]
 
Table 4. Fibrous Reaction Score
 
Findings of Immunostaining
In the replaced tissue section in groups B and C, after 24 weeks, a layer of the cells were positively stained for cytokeratin. These are likely to be mesothelium (Fig 5).



View larger version (117K):
[in this window]
[in a new window]
 
Fig 5. Immunostaining findings. In the replaced tissue sections in groups B and C after 24 weeks, a layer of the cells stained for cytokeratin and is likely mesothelium. (Left) Group B, 24 weeks (original magnification, x200). (Right) Group C, 24 weeks (original magnification, x200).

 

    Comment
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
Adhesion after open heart surgery is the greatest factor in causing longer operative and perfusion times, bleeding, and injury to the heart or great vessels. Many experimental and clinical attempts have been made to solve this problem by using different types of pericardial substitutes. The materials for these substitutes have included silicone rubber [1], polyurethane [2], fascia lata [3, 4], e-PTFE sheet [2, 5, 6], heterologous porcine, equine, or bovine pericardium [7–10], Dacron [11, 12], and dura mater [13].

Experimental results in animals have been far superior to the results of human clinical trials [5, 7, 20], which have demonstrated varying degrees of success. The reason for this difference is unclear, but Gabbay and colleagues [14] pointed out that it may be explained by blood clotting after cardiopulmonary bypass.

Of the synthetic sheets, those made from e-PTFE are superior to the others [5] and have been widely used as pericardial substitutes. The e-PTFE sheet has, however, a number of significant disadvantages; it remains in situ as a permanent foreign body and causes extensive inflammatory reaction. The use of such sheets might increase the incidence of mediastinitis [23]. Therefore, it was of interest to evaluate the host reaction to absorbable pericardial substitutes (gelatin sheet and L-C copolymer) in this study.

Moderate adhesion was observed between the pleura and the bioabsorbable materials at 4 weeks after implantation of the absorbable pericardial substitutes. However, the newly formed membranous tissue could be easily removed at 12 and 24 weeks after operation. Once bioabsorbable materials were totally absorbed, no host reaction remained [22].

Although the difference was not statistically significant for the L-C copolymer sheet, both absorbable pericardial substitutes had less adhesion than did the autologous pericardium and the e-PTFE sheet, a finding consistent with the report by Okuyama and associates [21]. When fibrous reaction causes adhesion, the first stage is the adherence of fibroblasts to the pericardial substitute. Then, fibroblasts proliferate and produce collagen fibers. There have been reports that the nature of the adhesion of cells to a material is related to the water content of the material [25]. Kulik and associates [25] reported that nonionic hydrogels exhibited minimal platelet adhesion at a water content of around 90%. The adhesion of fibroblasts may also be related to the water content of the material.

Microscopic examinations also revealed that whereas a strong foreign body reaction was present at 4 weeks after implantation, the number of infiltrating inflammatory cells was substantially reduced at 12 and 24 weeks after the operation. The gelatin sheet had less adhesion formation than did the L-C copolymer sheet. The extent of adhesion formation can be, at least in part, explained by the difference in the absorption rate. While the gelatin sheet needed 4 weeks to be totally absorbed, the L-C copolymer sheet needed 12 weeks. It is speculated that there is some relationship between the absorption rate and the degree of adhesion formation, but adhesion formation may be more closely related to the characteristics of the bioabsorbable materials.

In this study, where the section of tissue was replaced with a bioabsorbable pericardial substitute, a layer of the cells stained positively for cytokeratin and was likely mesothelium. Further investigation may be required to explain the origin of these cells.

There are several reports on the use of L-C copolymer sheet to repair defects in the dura mater, in experimental models. Among these reports, Yamada and coworkers [16] have reported that an L-C copolymer sheet is gradually absorbed and replaced by a dura-like connective tissue. In our study, bioabsorbable sheets were completely absorbed and replaced by fibrous membranous tissue. The gelatin sheet had less fibrous reaction than did the L-C copolymer sheet. The fibrous membranous tissue that replaced the L-C copolymer sheet had adequate strength, while only a very thin membrane was formed upon absorption of the gelatin sheet. Complete closure of the pericardial defect with membranous tissue formed after absorption of the pericardial substitute may adequately protect the heart from injury at the time of resternotomy, but avoidance of adhesion formation is a far more important component. The gelatin sheet is, therefore, still promising for clinical application as a pericardial substitute.

In conclusion, both the gelatin sheet and the L-C copolymer sheet were completely absorbed by 24 weeks after implantation. The gelatin sheet exhibited reduced formation of pleural and pericardial adhesions as compared with the e-PTFE sheet, at 12 and 24 weeks after implantation. Thus, gelatin sheet should be useful for reconstruction as an absorbable substitute. In the medium and late phases, gelatin sheets had permitted only slight adherence, and their complete absorption meant that no foreign body remained.


    References
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 

  1. Laks H, Hammond G, Ceha AS. Use of silicone rubber as a pericardial substitute to facilitate reoperation in cardiac surgery J Thorac Cardiovasc Surg 1981;82:88-92.[Abstract]
  2. Mester CA, Comas JV, Ninot S, et al. The use of polyetherurethane urea (Mitrathane) and polytetrafluoroethylene (Gore-Tex) membrane for pericardial closureinitial clinical results. Thai J Surg 1986:125-128.
  3. Kohanna FH, Adams PX, Cunningham JN, et al. Use of autologous fascia lata as a pericardial substitute following open-heart surgery J Thorac Cardiovase Surg 1977;74:14-19.
  4. Yu-Chin K. The repair of operative pericardial defect with fascia lata for the prevention and treatment of herniation of the heart Chin Med J 1959;78:210-213.[Medline]
  5. Revuelta JM, Gracia-Rinaldi P, Val F, et al. Expanded polytetrafluoroethylene surgical membrane for pericardial closure J Thorac Cardiovasc Surg 1985;89:451-455.[Abstract]
  6. Minale C, Hollweg G, Nicol S, et al. Closure of the pericardium using expanded polytetrafluoroethylene (Gore-Tex) surgical membraneclinical experience. J Thorac Cardiovasc Surg 1987;35:312-315.
  7. Gallo JI, Pomer JL, Artinano E, et al. Heterologous pericardium for the closure of pericardial defects Ann Thorac Surg 1987;26:149-154.
  8. Gallo JL, Artinano E, Duran CG. Late clinical result with the use of heterologous pericardium for the cardial cavity J Thorac Cardiovasc Surg 1985;89:709-712.[Abstract]
  9. Dietzman RH, Hotler AR, Lynch MF, et al. Protection of the heart during reoperation using a bovine pericardial shieldclinical experience. Contemp Surg 1984;24:35-39.
  10. Yakirevich VS, Abdulati SA, Abbott CR, et al. Reconstruction of the pericardial sac with glutaraldehyde preserved bovine pericardium Tex Heart Inst J 1984;11:238-242.[Medline]
  11. Youmans CR, White J, Derrick JR. The prevention of pleural and pericardial adhesions with Silastic J Thorac Cardiovasc Surg 1968;55:383-388.[Medline]
  12. Mazuji MK, Lett JC. Siliconized Dacron as a pericardial patch Arch Surg 1963;87:104-107.
  13. Bonnabeau RC, Armanious AW, Tarnay TJ. Partial replacement of pericardium with dura substitute J Thorac Cardiovasc Surg 1973;66:196-201.[Medline]
  14. Gabbay S, Guindy AM, Andrews JF, et al. New outlook on pericardial subsutitution after open heart operations Ann Thorac Surg 1989;48:803-812.[Abstract]
  15. Naoki O, Inui I, deZerega GS, Shimazaki Y. Development of bioabsorbable films for prevention of retrosternal adhesions Jpn J Artif Organs 1999;28:200-204.
  16. Yamada K, Miyamoto S, Nagata I, et al. Development of a dural substitute from synthetic bioabsorbable polymers J Neurosurg 1997;86:1012-1017.[Medline]
  17. Sakuma K, Tanaka Y, Watanabe S, et al. Closure of the pericardium using synthetic bioabsorbable polymers Jpn J Artif Organs 2000;29:233-238.
  18. Heydorn WH, Daniel JS, Wade CE. A new look at pericardial substitutes J Thorac Cardiovasc Surg 1987;94:291-296.[Abstract]
  19. Lu JH, Chang Y, Sung HW, Chiu YT, Yang PC, Hwang B. Heparinization on pericardial substitutes can reduce adhesion and epicardial inflammation in the dog J Thorac Cardiovasc Surg 1998;115:1111-1120.[Abstract/Free Full Text]
  20. Mathisen SR, Wu HD, Sauvage LR, Walker MW. Prevention of retrosternal adhesions after pericardiotomy J Thorac Cardiovasc Surg 1986;92:92-98.[Abstract]
  21. Okuyama N, Wang CY, Rose EA, et al. Reduction of retrosternal and pericardial adhesions with rapidly resorbable polymer films Ann Thorac Surg 1999;68:913-918.[Abstract/Free Full Text]
  22. Laquerriere A, Yun J, Hemet JTJ, Tadie M. Experimental evaluation of bilayered human collagen as a dural substitute J Neurosurg 1993;78:487-491.[Medline]
  23. Matsuyoshi T, Tachikawa Y, Takahashi H, et al. Treatment of postoperative mediastinitis using an omental pedicle flap Kyobugeka 1992;45:985-990.
  24. Miyazaki Y, Takeda M, Takada I. Fundamental and clinical studies on the absorbable gelatin film as dural substitute Brain Nerve 1969;21:1089-1098.
  25. Kulik E, Ikada Y. In vitro platelet adhesion to nonionic and ionic hydrogels with different water contents J Biomed Mater Res 1996;30:295-304.[Medline]



This article has been cited by other articles:


Home page
Asian Cardiovasc. Thorac. Ann.Home page
G. Matsumura, T. Shin'oka, Y. Ikada, T. Sakamoto, and H. Kurosawa
Novel Anti-Adhesive Pericardial Substitute for Multistage Cardiac Surgery
Asian Cardiovasc Thorac Ann, August 1, 2008; 16(4): 309 - 312.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
I. Yoshioka, Y. Saiki, K. Sakuma, A. Iguchi, T. Moriya, Y. Ikada, and K. Tabayashi
Bioabsorbable Gelatin Sheets Latticed With Polyglycolic Acid Can Eliminate Pericardial Adhesion
Ann. Thorac. Surg., September 1, 2007; 84(3): 864 - 870.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Masuda, Y. Saiki, S. Kawatsu, I. Yoshioka, H. Fujiwara, S. Kawamoto, S. Sai, A. Iguchi, N. Sakamoto, T. Ohashi, et al.
Trial of new vascular clips for aortic anastomosis in a canine model
J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 723 - 730.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. Chang, P.-H. Lai, C.-C. Wang, S.-C. Chen, W.-C. Chang, and H.-W. Sung
Mesothelium regeneration on acellular bovine pericardia loaded with an angiogenic agent (ginsenoside Rg1) successfully reduces postsurgical pericardial adhesions
J. Thorac. Cardiovasc. Surg., October 1, 2006; 132(4): 867 - 874.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Kei Sakuma
Koichi Tabayashi
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sakuma, K.
Right arrow Articles by Tabayashi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sakuma, K.
Right arrow Articles by Tabayashi, K.
Related Collections
Right arrow Pericardium


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS